OC-10X

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameOC-10X
Drug Alias NameOC-10XSC-2-71
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBangladesh
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOcucure Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOcucure Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A